Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-112394 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CYP2C18 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1.09 mg/mL
- Storage
- -20°C or -80°C if preferred
Submitted references Revisiting an Expression Dataset of Discordant Inflammatory Bowel Disease Twin Pairs Using a Mutation Burden Test Reveals CYP2C18 as a Novel Marker.
Du J, Yin J, Du H, Zhang J
Frontiers in genetics 2021;12:680125
Frontiers in genetics 2021;12:680125
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot analysis of CYP2C18 in multiple sample types using a CYP2C18 polyclonal antibody (Product # PA5-112394) at a concentration of 5.98 µg/ml. A goat anti rabbit polyclonal secondary antibody was used at a dilution of 1:10,000. Sample types that were tested include: Lane 1: HL60 whole cell lysate, Lane 2: 293T whole cell lysate.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemical analysis of paraffin-embeded CYP2C18 in human liver cancer using a CYP2C18 Polyclonal antibody (Product # PA5-112394) at a dilution of 1:100.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemical analysis of paraffin-embeded CYP2C18 in human small intestine tissue using a CYP2C18 Polyclonal antibody (Product # PA5-112394) at a dilution of 1:100.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- FIGURE 7 The expression level of CYP2C18 was upregulated in colorectal cancer cell lines and UC-affected cases. (A) The expression level of CYP2C18 was highly increased after TNF-alpha stimulation. (B) Representative images of immunohistochemistry staining of CYP2C18 in UC affected cases and normal individuals. Scale bar: 100 mum.
